Information Journal Paper
APA:
Copy. (2018). Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. LANCET, 391(10117), 205-218. SID. https://sid.ir/paper/739255/en
Vancouver:
Copy. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. LANCET[Internet]. 2018;391(10117):205-218. Available from: https://sid.ir/paper/739255/en
IEEE:
Copy, “Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial,” LANCET, vol. 391, no. 10117, pp. 205–218, 2018, [Online]. Available: https://sid.ir/paper/739255/en